Comparing the cardiac autonomic activity profile of daytime naps and nighttime sleep. by Whitehurst, Lauren N et al.
UC Irvine
UC Irvine Previously Published Works
Title
Comparing the cardiac autonomic activity profile of daytime naps and nighttime sleep.
Permalink
https://escholarship.org/uc/item/7r52v1cq
Journal
Neurobiology of sleep and circadian rhythms, 5(Sleep Med. 8 2007)
ISSN
2451-9944
Authors
Whitehurst, Lauren N
Naji, Mohsen
Mednick, Sara C
Publication Date
2018-06-01
DOI
10.1016/j.nbscr.2018.03.001
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Contents lists available at ScienceDirect
Neurobiology of Sleep and Circadian Rhythms
journal homepage: www.elsevier.com/locate/nbscr
Comparing the cardiac autonomic activity proﬁle of daytime naps and
nighttime sleep
Lauren N. Whitehursta,⁎, Mohsen Najib, Sara C. Mednickc
a Department of Psychology, University of California, 900 University Ave Riverside, Riverside 92507, CA, USA
bDepartment of Medicine, University of California San Diego, La Jolla
c Department of Cognitive Sciences, University of California, Irvine
A R T I C L E I N F O
Keywords:
Napping
Cardiovascular
Health
Heart rate variability
Autonomic
sleep
A B S T R A C T
Heart rate variability (HRV) is a reliable technique to evaluate autonomic activity and shows marked changes
across a night of sleep. Previous nighttime sleep ﬁndings report changes in HRV during non-rapid eye movement
sleep (NREM), which have been associated with cardiovascular health beneﬁts. Daytime sleep, however, has
been linked with both positive and negative cardiovascular outcomes. Yet, no studies have directly compared
HRV proﬁles during an ecologically-valid daytime nap in healthy, well-rested adults to that of nighttime sleep.
Using a within-subjects design, 32 people took a daytime nap and slept overnight in the lab at least one week
apart; both sleep sessions had polysomnography, including electrocardiography (ECG), recorded. We measured
inter-beat intervals (RR), total power (TP), low frequency power (LF; .04–.15 Hz), and high frequency power
(HF; .15–.40 Hz) components of HRV during NREM and rapid eye movement (REM) sleep. Compared to the nap,
we found longer RR intervals and decreased heart rate during the night for both Stage 2 and SWS and increased
TP, LF and HF power during nighttime Stage 2 sleep only; however, no diﬀerences in the LFHF ratio or nor-
malized HF power were found between the nap and the night. Also, no diﬀerences in REM sleep between the nap
and night were detected. Similar relationships emerged when comparing the nap to one cycle of nighttime sleep.
These ﬁndings suggest that longer daytime naps, with both SWS and REM, may provide similar cardiovascular
beneﬁts as nocturnal sleep. In light of the on-going debate surrounding the health beneﬁts and/or risks asso-
ciated with napping, these results suggest that longer daytime naps in young, healthy adults may support cardiac
down-regulation similar to nighttime sleep. In addition, napping paradigms may serve as tools to explore sleep-
related changes in autonomic activity in both healthy and at-risk populations.
1. Introduction
Sleep inﬂuences the cardiovascular system, with distinct changes in
cardiac activity occurring at sleep onset and within individual sleep
stages (Trinder et al., 2012). Fluctuations in cardiac activity across
sleep and wake are understood to homeostatically regulate the balance
between the sympathetic and parasympathetic branches of the auto-
nomic nervous system (ANS), where waking is primarily supported by
sympathetic activity and sleep is dominated by parasympathetic/vagal
activity. Increases in parasympathetic activity during nighttime sleep
have been correlated with reduced risk for cardiovascular disease
(Thayer et al., 2010), leading researchers to describe nighttime sleep as
a “cardiovascular holiday” (Trinder et al., 2012). In contrast, the re-
lationship between cardiac autonomic activity and daytime sleep is not
as clear. Epidemiological studies have reported that frequent napping is
associated with both increased (Leng et al., 2014) and decreased (Naska
et al., 2007) risk for cardiovascular mortality. While discrepancies be-
tween studies may be due to a range of confounding factors, including
comorbid psychological and health problems as well as demographic
and population diﬀerences; due to the lack of empirical investigations,
the reasons for these discrepancies between studies is not known.
However, circadian inﬂuences on both sleep (Borbély and Achermann,
1999) and cardiovascular activity (Guo and Stein, 2003) suggest day-
time naps may confer less restorative beneﬁt than a night of sleep; and
though a similar cardiac proﬁle between the two sleep phases has been
suggested in healthy adults (Cellini et al., 2016, 2017), no study has
directly compared the cardiac proﬁle of a nap to a night of sleep, which
is the goal of the current study.
The lack of empirical investigations into the relationship between
napping and cardiovascular modulation is surprising considering that
cardiovascular disease is the leading cause of death in the United States
(Benjamin et al., 2017) and, according to the National Sleep
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Foundation, 53% of adults in America nap at least once in a 7-day
period for at least 15min a day (National Sleep Foundation, 2014). In
other healthy, adult samples, 60–75% of adults’ nap at least one time in
a 7-day week with average nap durations of about 70min (Dinges,
1992; Pilcher et al., 2010). Considering napping is a common practice,
it is important to determine if and under which conditions naps have
the potential to either exacerbate or reduce the risk for cardiovascular
disease. Additionally, experimental studies increasingly use naps to
assess the eﬀect of sleep for cognitive ﬁtness and memory consolida-
tion. Even more, cardiac, autonomic activity during naps has recently
been shown to be a strong predictor of memory improvement
(Whitehurst et al., 2016). Therefore, a thorough, direct assessment
comparing the autonomic proﬁle of a nap and nighttime sleep is ne-
cessary.
A typical measure of cardiac, autonomic activity is heart-rate
variability (HRV), a non-invasive, well-established technique, extracted
from the beat-to-beat interval (RR interval) and detected from an
electrocardiogram (ECG). Two oscillatory components that characterize
the RR interval –the low frequency component (LF; .04–.15 Hz) and the
high frequency component (HF; .15–.40 Hz) –have been independently
tied to underlying ANS mechanisms (Tobaldini et al., 2013). The HF
component is partially representative of parasympathetic outﬂow and
vagal activity (Berntson et al., 1997), and while consensus is lacking
regarding the interpretation of the LF component (Billman, 2013), it is
purported to account for sympathetic activity and some vagal mod-
ulations (Stein et al., 1994; Berntson et al., 1997; Malliani et al., 1991).
In healthy adults, sleep onset is characterized by a reduction in
overall heart rate (i.e., a lengthening in the RR interval) and increased
HF power (Trinder et al., 2012). As people cycle through non-rapid eye
movement sleep (NREM), comprised of stages 1–3 [(with Stage 3
commonly referred to as slow wave sleep SWS)], studies have shown a
continued lengthening of RR intervals, decreased LF, but not HF power,
and decreased LF/HF ratios compared to both wake and REM sleep
(Trinder et al., 2001). These ﬁndings indicate an overall reduction in
cardiovascular output and dominance of parasympathetic and vagal
activity during NREM sleep.
Here, we utilized a within-subjects design with each subject un-
dergoing a 2-hour daytime nap opportunity and a night of sleep in the
lab, at least one week apart, while being monitored with poly-
somnography (PSG), including electrocardiography (ECG). We assessed
cardiac autonomic activity within each sleep stage (Stage 2, SWS, and
REM) of the nap and night condition. We anticipated similar autonomic
activity for all HRV variables across both nap and night conditions.
2. Materials and methods
Thirty-two healthy, non-smoking participants between the ages of
18 to 35 (Mage = 21.00±2.4 years, 16 Females) with no personal
history of neurological, psychological, or other chronic illness provided
informed consent, which was approved by both the Western
Institutional Review Board and the University of California, Riverside
Human Research Review Board. Participants received monetary com-
pensation and/or course credit. Individuals were excluded from parti-
cipation if they reported: irregular sleep/wake cycles; a sleep disorder
(determined during an in-person interview); personal or familial history
of diagnosed psychopathology; substance abuse/dependence; loss of
consciousness greater than 2min or a history of epilepsy; current use of
psychotropic medications; and any cardiac or respiratory illness that
may aﬀect cerebral metabolism.
2.1. Protocol
All participants wore an actigraph and completed daily sleep diaries
for one week prior to in-lab visits to ensure participants were not sleep-
deprived, received an average of 7 h of sleep per night, and spent at
least 6.5 h in bed the night prior to each visit. Each participant had a
daytime nap and a nighttime sleep session (on diﬀerent days) mon-
itored with PSG and ECG. For the nap session, participants were allotted
2 h of time in bed between 1:30–3:30PM and a trained sleep technician
monitored all naps in real-time to ensure subjects were asleep within
30min of lights out. Midday naps, which provide normal, healthy
sleepers the opportunity to fully cycle through Stage 2, SWS, and REM,
were used to optimize the chance that all subjects would obtain ade-
quate time in each sleep stage. Nighttime sleep was recorded from
subjects on a day other than their nap day (at least 1 week apart and
counterbalanced) to eliminate confounds due to reductions in sleep
pressure after the nap.
2.2. Polysomnography (PSG)
PSG data were collected using Astro-Med Grass Heritage Model 15
ampliﬁers with Grass GAMMA software. Scalp electroencephalographic
(EEG) and electrooculagraphic (EOG) electrodes were referenced to
unlinked contralateral mastoids (F3/A2, F4/A1, C3/A2, C4/A1, P3/A2,
P4/A1, O1/A2 O2/A1, LOC/A2, ROC/A1). Two submental muscle tone
electromyographic (EMG) electrodes were attached under the chin and
referenced to each other. High pass ﬁlters were set at .3 Hz and low pass
ﬁlters at 35 Hz for EEG and EOG. Raw data were visually scored in 30-
sec epochs according to the Rechtschaﬀen & Kales’ (1968) manual.
2.3. Cardiac assessment
Electrocardiogram (ECG) data were collected at 256 Hz sampling
rate using a modiﬁed Lead II Einthoven conﬁguration. R-wave peaks
were detected automatically by Kubios HRV Analysis Software 2.0
(Matlab, Kuopio, Finland), visually examined, and edited for artifacts.
An independent lab tool was employed to perform the HRV analysis of
the R-waves series through both nap and nighttime sleep periods ac-
cording to the Task Force of the European Society of Cardiology and
North American Society of Pacing and Electrophysiology guidelines
(Camm et al., 1996). Missing and ectopic beats were corrected via cubic
spline interpolation. Inter-beat intervals were computed and a third
order polynomial ﬁlter was applied on the time series to remove non-
stationary trend components and increase estimation of the LF com-
ponent (Tarvainen et al., 2014; Weber et al., 1992). An autoregressive
model (model order set at 16; Boardman et al., 2002) was employed to
quantify the absolute spectral power (ms2) in the LF and HF frequency
bands and the total power (TP), which reﬂects total HRV. The LF, HF,
and TP measures had skewed distributions and as such were trans-
formed by taking the natural logarithm. From these variables we de-
rived the HF normalized units (HFnu= (HF [ms2]/ HF [ms2] + LF
[ms2])*100) and the LFHF ratio (LF / HF). Since the LF normalized
units are mathematically reciprocal to HFnu (i.e. LFnu =1- HFnu), to
avoid redundancy, we computed only the HFnu index. Additionally, we
included the RR interval as a major index of cardiac autonomic control
(Pinna et al., 2007) as well as heart rate (HR), measured as beats per
minutes (bpm), in our analyses.
For the analysis of RR, HR and frequency-domain HRV measures
during diﬀerent sleep stages, consecutive, artifact-free windows of un-
disturbed sleep were selected across both the night and nap. Each
window was 3-min in duration and the 2-min preceding and the entire
3-min epoch were free from stage transitions. Windows were identiﬁed
and averaged within Stage 2, SWS and REM sleep. Epochs of Stage 1
and wake after sleep onset were not analyzed (Trinder, et al., 2001).
2.4. Data reduction and statistical analyses
Our method of HRV analyses emphasizes consolidated sleep stages.
As a result, for subjects that could not attain at least 5 min of un-
disturbed sleep in any given sleep stage, we were unable to calculate
HRV parameters. This disproportionately impacted the nap condition
with four subjects not acquiring enough consolidated SWS and three
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subjects not acquiring enough consolidated REM. Additionally, the ECG
lead was disturbed in three nighttime and nine nap recordings, and as a
result, the RR interval could not be calculated during SWS or REM.
These records were removed from those analyses. Lastly, one subject
was removed as an outlier (values greater than 2.5 standard deviations
from the mean). The ﬁnal sample size for nighttime records was as
follows Stage 2 = 29; SWS = 28; REM = 29 and the ﬁnal sample sizes
for the nap records was as follows: Stage 2 = 30; SWS = 18; REM =
19.
First, to ensure that the cardiac proﬁle in our sample was similar to
that previously reported, we performed repeated measures ANOVAs on
the nighttime records for each of the HRV variables (RR, HR, LF, HF,
TP, HFnu, LFHF) with sleep stage (Stage 2, SWS, and REM) as a within-
subjects factor. The Huynh-Feldt correction was applied when spheri-
city assumptions were violated. Tukey’s HSD test with the Bonferonni
correction were used for post-hoc comparisons and partial eta squared
(η2p) is reported for eﬀect size.
Here, our main goal was to directly assess if HRV parameters diﬀer
during a nap compared to nighttime sleep. To examine this goal, we
conducted three multivariate ANOVA’s for each sleep stage (Stage 2,
SWS, REM) with HRV parameters (HR, RR, LF, HF, TP, HFnu, LFHF) as
dependent variables and condition (Nap vs Night) as a ﬁxed factor. We
included minutes in each sleep stage (Stage 2, SWS, REM) as a covariate
in each model and report partial eta squared (η2p) for eﬀect size.
Due to homeostatic and circadian controls of sleep, there are var-
iations in the amount of sleep present in each sleep cycle, with the ﬁrst
sleep cycle comprised primarily of SWS sleep, the last sleep cycle ty-
pically presenting with increased REM and intermediate cycles having
comparable amounts of both SWS and REM (see Borbély and
Achermann, 1999 for full description). To determine if cardiac auto-
nomic activity during a daytime nap is analogous to a cycle of nighttime
sleep, we conducted secondary analyses where we compared each of
our HRV parameters during the nap to a sole sleep cycle. Here, we used
the second cycle of nighttime sleep to be able to compare the nap to
adequate amounts of each nighttime sleep stage: Stage 2 (N = 29), SWS
(N = 26), and REM sleep (N = 27; for deﬁnition of cycles, please see
Feinberg and Floyd, 1979). We utilized the same statistical MANOVA
models as in the full night analyses. Here, we also controlled for the
number of minutes contributing to the HRV analysis in that cycle of
sleep.
3. Results
3.1. HRV proﬁle during nighttime sleep
Sleep architecture for both nights and naps can be found in Table 1.
Nighttime sleep showed signiﬁcant diﬀerences in RR intervals across
sleep stages, p<0.001, η2p = 0.30 with longer RR intervals during
NREM Stage 2 when compared to REM (p< .001), as well as longer RR
intervals during Stage 2 when compared to SWS (p<0.001). However,
we found no diﬀerence between RR intervals during SWS and REM (p
= 0.42). A similar relationship was found for HR with higher heart rate
in SWS (p = 0.001) and REM (p<0.001) when compared to Stage 2,
however no diﬀerences between SWS and REM (p = 0.12). We also
found changes in TP across nighttime sleep states, p<0.001, η2p =
0.48, with higher TP in both Stage 2 (p< .001) and REM (p< .001)
when compared to SWS. Changes in TP across sleep states was derived
from changes in both LF (p<0.001, η2p = 0.53) and HF activity (p =
0.002, η2p = 0.22). Speciﬁcally, LF activity was lowest in SWS and
signiﬁcantly lower during SWS when compared to both Stage 2
(p<0.001) and REM (p<0.001), and HF activity was lower in SWS
when compared to Stage 2 (p = 0.001). No diﬀerences emerged be-
tween Stage 2 and REM sleep for either LF (p = 0.73) or HF activity (p
= 0.74). These changes in raw power were also reﬂected in both HFnu
(p<0.001, η2p = 0.61) and LFHF (p<0.001, η2p = 0.56). For HFnu, we
found increased power during SWS compared to both Stage 2
(p< .001) and REM (p< .001), and increased activity in Stage 2
compared to REM (p<0.001). In contrast, for LFHF, the lowest ratio
emerged during SWS, which was signiﬁcantly lower than both Stage 2
(p< .001) and REM sleep (p<0.001). Stage 2 also had a lower LFHF
ratio when compared to REM (p< .001). For nap sleep stage compar-
isons see Supplemental Fig. 1.
In line with previous literature, these data replicate the relative
dominance of parasympathetic (HFnu) activity during NREM when
compared to REM sleep, which is driven by a reduction in LF activity
and an increase in HF activity during NREM sleep (Table 2, see Fig. 1a-
f).
3.2. HRV proﬁle of a nap vs. nighttime sleep: Whole night analyses
Comparing nap vs. night, after controlling for minutes in each sleep
stage, we found diﬀerences in Stage 2 across a nap and a night, p =
0.05, η2p = 0.21. Speciﬁcally, during Stage 2 sleep, we found sig-
niﬁcantly longer RR intervals (p = 0.001, η2p = 0.16) and lower HR (p
= 0.002, η2p = 0.15) at night compared to the nap. Additionally, there
was higher TP (p = 0.01, η2p = 0.11), LF (p = 0.04, η2p = 0.07) and HF
(p= 0.03, η2p = 0.08) activity during the night compared to the nap. No
diﬀerences in the LFHF ratio p = 0.47, η2p = 0.009 or HFnu power p =
0.47, η2p = 0.09 emerged between the nap and night for Stage 2 sleep.
For SWS, diﬀerences between RR intervals also emerged; a MANOVA
showed longer RR intervals during nighttime sleep when compared to
the nap, p = 0.01, η2p = 0.14 coupled with a higher heart rate during
the nap compared to the night (p = 0.04, η2p = 0.09). No other dif-
ferences between a nap and a night in SWS were present. Additionally,
none of the seven cardiac parameters diﬀered across a night and a nap
for REM sleep (p = 0.59, η2p = 0.10).
Table 1
Demographics.
Mean (SD) N (%)
Age (years) 20.77 (2.20)
BMI (kg/m2) 23.26 (3.31)
Female/Male 16 / 16 (50 / 50)
Ethnicity
African-American 2 (6)
Asian 4 (13)
Hispanic 15 (47)
Caucasian 3 (9)
Mixed (2 or more) 4 (13)
Other 4 (13)
Note: BMI = Body Mass Index; SD = Standard Deviation.
Table 2
Descriptive statistics for nap and nighttime sleep.
Nap Night
Mean Min Max Mean Min Max
TST 96.36 (19.56) 36.50 116.50 480.53 (66.67) 162.00 571.00
Stage 1 14.34 (17.29) 3.00 101.00 7.02 (5.13) 0 20.50
Stage 2 50.45 (21.06) 0 83.00 256.23 (51.64) 96.50 356.50
SWS 17.86 (14.61) 0 54.00 96.08 (32.45) 24.00 147.00
REM 13.70 (12.85) 0 54.00 121.20 (39.50) 40.50 217.00
WASO 12.36 (16.20) 0.50 67.50 30.63 (11.50) 14.00 52.50
SL 5.92 (6.28) 1.00 27.50 9.52 (12.12) 0.50 63.50
SE % 83.52 (16.58) 30.40 96.80 92.15 (3.18) 83.30 97.20
Note: Mean (Standard Deviation); TST = Total Sleep Time; SWS = Slow Wave
Sleep; REM = Rapid Eye Movement sleep; WASO = Wake After Sleep Onset
(calculated as the minutes of wake after ﬁrst epoch of sleep); SL = Sleep
Latency (calculated as the time to ﬁrst epoch of sleep); SE = Sleep Eﬃciency.
All stats are represented in minutes besides SE which is in percentage.
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3.3. HRV proﬁle of a nap vs. nighttime sleep: cycle analyses
Next, we examined how the daytime nap compared to the second
cycle of nighttime sleep. Similar to the whole night analyses, for Stage
2, we found signiﬁcant diﬀerences between the second cycle of night-
time sleep and a daytime nap (p= 0.009, η2p = 0.28) with a lower heart
rate at night compared to the nap (p = 0.002, η2p = 0.16), as well as
higher LF (p= 0.02, η2p = 0.09), HF (p= 0.04, η2p = 0.07) and TP (p=
0.03, η2p = 0.08) activity. Importantly, for Stage 2 sleep, we found no
diﬀerence between LFHF (p = 0.46, η2p = 0.01) or HFnu (p = 0.30, η2p
= 0.02). Even more, no diﬀerences between the second cycle of SWS (p
= 0.18, η2p = 0.21) or REM sleep (p=0.73, η2p =0.07) and the daytime
nap were detected. Reliability between cycles for nighttime sleep can be
found in Supplemental Table 1.
4. Discussion
In the current study, we directly compared alterations in cardiac,
autonomic activity during both a daytime nap and nighttime sleep in a
within-subjects design. Similar to previous studies, nighttime sleep
showed dominance of parasympathetic activity during NREM sleep
when compared to REM, which was reﬂected in decreased LF power
and reduced LFHF ratios, as well as increased HF and HFnu power
during both Stage 2 and SWS when compared to REM.
Comparing a nap to a night, in Stage 2 only, we found higher TP, as
well as higher HF and LF activity during nighttime sleep compared with
naps, and in Stage 2 and SWS, we found longer RR intervals and lower
heart rates at night compared to the night. No diﬀerences in REM sleep
were found between night and daytime sleep, and importantly, no
diﬀerences in either the LFHF ratio or HFnu power were present for any
of the sleep stages. These relationships were maintained in our cycle
analyses where we compared HRV features during the second cycle of
nighttime sleep to respective aspects of the nap. This suggests that the
relative increases in parasympathetic activity present during nighttime
sleep, and related to cardiovascular health, are also present during a
daytime nap. These data suggest that, like a night of sleep, a nap can
serve as a “mini-cardiovascular” break.
4.1. HRV: Naps vs Nocturnal sleep
Our results extend previous studies on daytime sleep (Cellini et al.,
2016, 2017), and the role of circadian eﬀects on sleep-dependent car-
diac proﬁles (Boudreau et al., 2013). One comparable study (Boudreau
et al., 2013) used a forced 72-hour ultradian sleep/wake protocol and
found that there are less sleep-pronounced changes in RR, HF, LF and
LFHF ratios during the day when compared to the night. We found a
similar eﬀect here, with shorter RR intervals, higher TP, LF and HF
activity during the day compared to the night. However, importantly,
changes in TP, LF and HF activity were only found to diﬀer in Stage 2
sleep and were not as widely prevalent across sleep stages as previously
reported (Boudreau et al., 2013). However, due to the strict circadian
control of the Boudreau et al. (2013) study (one hour nap opportunities
every other hour for three days), the amount of sleep observed (mean
nap time 27min) was limited, which consequently truncated the
amount of time in each sleep stage used for analyses. Furthermore,
sleep-deprivation may have played a role in the prior results. Here,
using a paradigm in which well-rested subjects were provided a 2-hour
daytime nap opportunity, we expand upon these prior ﬁndings and
suggest instead that daytime circadian eﬀects may emerge the most
strongly during lighter, Stage 2 sleep. On the other hand, during deeper
sleep states (SWS and REM), sleep regulatory eﬀects appear more
pronounced. This suggests that longer daytime naps that include SWS
and REM sleep (e.g., 45–90min) may show more cardiac beneﬁts.
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Fig. 1. a-g. Cardiac HRV parameters across a daytime nap (grey bars) and nighttime sleep (black bars). Asterisks indicate signiﬁcant diﬀerences (p<0.05) between
nap and night within the sleep stage for the given HRV parameter. Error bars represent standard error of the mean.
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4.2. Cardiovascular health, cognitive ﬁtness and napping behaviors
There has been a signiﬁcant debate in the literature surrounding the
beneﬁts of napping for health and cognition, with some research
showing that napping is correlated with increased nighttime sleep
disruption (Owens et al., 2010), excessive daytime sleepiness and de-
pression (Foley et al., 2007), as well as cardiovascular mortality (Leng
et al., 2014); while others report associations between napping with
normal nighttime sleep, as well as distinct cognitive and health beneﬁts
including increased cognitive alertness, decreased daytime sleepiness,
and decreased risk for heart attack and coronary death (Jung et al.,
2013; Leng et al., 2014; Dhand and Sohal, 2006; Gillberg et al., 1996;
Naska et al., 2007). These discrepancies may be related to a range of
factors, including comorbid psychological and health problems and
demographic diﬀerences as well as cultural context. In addition, rea-
sons for napping may predict diﬀerences in nap beneﬁts. In a college
sample, Duggan et al. (2016) used factor analysis to categorize people’s
reasons for napping into a ﬁve-factor DREAM model: “Dysregulative”
(napping due to disturbed sleep schedules), “Restorative” (napping to
prepare or make up for sleep loss), “Emotional” (napping due to stress,
depression or boredom), “Appetitive” (napping for enjoyment), and
“Mindful” (napping to increase cognitive ability). These factors were
compared with self-reported sleep, psychological, and physical health.
The ﬁndings suggest that only Emotional reasons for napping were
associated with negative health outcomes (Duggan et al., 2016). No
studies have examined whether nap habits and reasons for napping may
be related to health predictors. Additionally, current studies on napping
do not discern between planned and accidental naps. This may be an
important distinction as it has been shown that planned naps are as-
sociated with cognitive and health beneﬁts, while accidental naps are
suggestive of an underlying sleep or health disorder (Dhand and Sohal,
2006). Taken together, these results suggest that understanding why
and how people are napping is essential when considering potential
health or psychological outcomes.
4.3. Limitations
The current sample was comprised of young, healthy adults with no
history of physical or psychiatric illness. Many studies reporting nega-
tive associations between napping and health outcomes utilize older
and/or unhealthy populations (Jung et al., 2013; Leng et al., 2014).
Considering cardiac activity is a signiﬁcant factor for populations at risk
for cardiovascular disease (Legramante and Galante, 2005) and HRV
assessments during sleep have been shown to be useful in risk stratiﬁ-
cation, or determination of an individual’s need for preventative
treatment (Stein and Pu, 2012), it would be helpful to measure HRV
proﬁles during daytime sleep in clinical samples to gain a better un-
derstanding of sleep and cardiovascular modulations in healthy and at-
risk populations. Additionally, research has shown that hormonal
ﬂuctuations associated with female’s menstrual phase can interact with
both nap (Genzel et al., 2012) and nighttime sleep features (Baker and
Driver, 2007). In future investigations, accounting for menstrual cycle
related ﬂuxes is an important consideration.
Another limitation of this study is the reduction in subject numbers
due to HRV methodological constraints. Speciﬁcally, standard practice
for HRV analyses (Camm et al., 1996; Cellini et al., 2015) requires as-
sessment of HRV over a ﬁve-minute period of a consistent sleep stage.
Due to the large amount of sleep transitions present in a daytime nap,
this approach limits the total amount of data available and likely im-
pacts statistical power. Speciﬁcally, 5 min of undisturbed sleep in each
sleep stage is not as common in daytime naps and reduces the total
sample. While we don’t believe that the reduction in power was a
substantially limiting factor in the current study, in order to retain more
statistical power, future studies should explore alternative methodolo-
gical approaches to HRV assessment.
Conﬂicts of interest
None.
Funding
This work was supported by the National Institutes of Health
(1R01AG046646).
Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.nbscr.2018.03.001.
References
Baker, F.C., Driver, H.S., 2007. Circadian rhythms, sleep and the menstrual cycle. Sleep
Med. 8, 613–622. http://dx.doi.org/10.1016/j.sleep.2006.09.011.
Berntson, G.G., et al., 1997. Heart rate variability: origins, methods and interpretive
caveats. Psychophysiology 34, 623–648.
Benjamin, E.J., et al., 2017. On behalf of the American Heart Association Statistics
Committee and Stroke Staitstics Subcommittee. Heart disease and stroke statis-
tics—2017 update: a report from the American Heart Association. Circulation. http://
dx.doi.org/10.1161/CIR.00000000000000485.
Billman, G.E., 2013. The LF/HF ratio does not accurately measure cardiac sympatho-
vagal balance. Front. Physiol. 4, 26.
Boardman, A., Schlindwein, F.S., Rocha, A.P., Leite, A., 2002. A study on the optimum
order of autoregressive models for heart rate variability. Physiol. Meas. 23, 325–336.
Borbély, A.A., Achermann, P., 1999. Sleep homeostasis and models of sleep regulation. J.
Biol. Rhythm. 14, 557–568.
Boudreau, P., Yeh, W.-H., Dumont, G.A., Boivin, D.B., 2013. Circadian variation of heart
rate variability across sleep stages. Sleep 36, 1919.
Camm, A., Malik, M., Bigger, J., Breithardt, G., Cerutti, S., Cohen, R., Kleiger, R., 1996.
Heart rate variability: standards of measurement, physiological interpretation and
clinical use. Task Force of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology. Circulation 93, 1043–1065.
Cellini, N., Torre, J., Steggno, L., Sarlo, M., 2017. Cardiac autonomic activity during
daytime nap in young adults. J. Sleep Res. http://dx.doi.org/10.1111/jsr.12539.
Cellini, N., Whitehurst, L.N., McDevitt, E.A., Mednick, S.C., 2016. Heart rate variability
during daytime naps in healthy adults: autonomic proﬁle and short-term reliability.
Psychophysiology 53, 473–481.
Dhand, R., Sohal, H., 2006. Good sleep, bad sleep! The role of daytime naps in healthy
adults. Curr. Opin. Pulm. Med. 12, 379–382.
Dinges, D.F., 1992. Adult napping and its eﬀects on ability to function. In: Stampi, C.
(Ed.), Evolution, Chronobiology, and Functions of Polyphasic and Ultrashort Sleep.
Birkhauser, Boston, pp. 118–134.
Duggan, K.A., McDevitt, E.A., Whitehurst, L.N., Mednick, S.C., 2016. To nap, perchance to
DREAM: a factor analysis of self-reported reasons for napping. Behav. Sleep Med.
http://dx.doi.org/10.1080/15402002.2016.1178115.
Feinberg, I., Floyd, T.C., 1979. Systematic trends across the night in human sleep cycles.
Psychophysiology 16, 283–291. http://dx.doi.org/10.1111/j.1469-8986.1979.
tb02991.x.
Foley, D.J., Vitello, M.V., Bliwise, D.L., Ancoli-Israel, S., Monjan, A.A., Walks, J.K., 2007.
Frequent napping is associated with excessive daytime sleepiness, depression, pain,
and nocturia in older adults: ﬁndings from the National Sleep Foundation ‘2003 Sleep
in America’ poll. Am. J. Geriatr. Psychiatry 15, 344–350.
Genzel, L., Kiefer, T., Renner, L., Dressler, M., 2012. Sex and modulatory menstrual cycle
eﬀects on sleep related memory consolidation. Psychoneuroimmunology 37,
987–998. http://dx.doi.org/10.1016/j.psyneuen.2011.11.006.
Gillberg, M., Kecklund, G., Axelsson, J., Akerstedt, T., 1996. The eﬀects of a short daytime
nap after restricted night sleep. Sleep 19, 570–575.
Guo, Y., Stein, P.K., 2003. Circadian rhythm in the cardiovascular system: chron-
ocardiology. Am. Heart J. 145, 779–786.
Legramante, J.M., Galante, A., 2005. Sleep and hypertension: a challenge for the auto-
nomic regulation of the cardiovascular system. Circulation 112, 786–788.
Leng, Y., Wainwright, N.W., Cappuccio, F.P., Surtees, P.G., Hayat, S., Luben, R., Khaw, K.-
T., 2014. Daytime napping and the risk of all-cause and cause-speciﬁc mortality: a 13-
year follow-up of a British population. Am. J. Epidemiol. 179, 1115–1124.
Malliani, A., Pagani, M., Lombardi, F., Cerutti, S., 1991. Cardiovascular neural regulation
explored in the frequency domain. Circulation 84, 482–492.
Naska, A., Oikonomou, E., Trichopoulou, A., Psaltopoulou, T., Trichopoulos, D., 2007.
Siesta in healthy adults and coronary mortality in the general population. Arch. Int.
Med. 167, 296–301.
National Sleep Foundation, 2014. Sleep Health Index. 〈http://sleepfoundation.org/sleep-
health-index〉.
Owens, J.F., Buysse, D.J., Hall, M., et al., 2010. Napping, nighttime sleep, and cardio-
vascular risk factors in mid-life adults. J. Clin. Sleep Med. 6, 330–335.
Pilcher, J.J., Michalowski, K.R., Carrigan, R.D., 2010. The prevalence of daytime napping
and its relationship to nighttime sleep. Behav. Med. 27, 71–76.
Pinna, G., Maestri, R., Torunski, A., Danilowicz-Szymanowicz, L., Szwoch, M., La Rovere,
M., Raczak, G., 2007. Heart rate variability measures: a fresh look at reliability. Clin.
L.N. Whitehurst et al. Neurobiology of Sleep and Circadian Rhythms 5 (2018) 52–57
56
Sci. 113, 131–140.
Stein, P.K., Pu, Y., 2012. Heart rate variability, sleep and sleep disorders. Sleep Med. Rev.
16, 47–66.
Stein, P.K., Bosner, M.S., Kleiger, R.E., Conger, B.M., 1994. Heart rate variability: a
measure of cardiac autonomic tone. Am. Heart J. 127, 1376–1381.
Tarvainen, M.P., Niskanen, J.P., Lippponen, P.O., Ranta-aho, Karjalainen, P.A., 2014.
Kubios hrv-heart rate variability analysis software. Comp. Methods Prog. Biomed.
113, 210–220.
Thayer, J.F., Yamamoto, S.S., Brosschot, J.F., 2010. The relationship of autonomic im-
balance, heart rate variability and cardiovascular disease risk factors. Int. J. Cardiol.
141, 122–131.
Tobaldini, E., Nobili, L., Strada, S., Casali, K.R., Braghiroli, A., Montano, N., 2013. Heart
rate variability in normal and pathological sleep. Front. Physiol. 4. http://dx.doi.org/
10.3389/fphys.2013.00294.
Trinder, J., Kleiman, J., Carrington, M., Smith, S., Breen, S., Tan, N., Kim, Y., 2001.
Autonomic activity during human sleep as a function of time and sleep stage. J. Sleep
Res. 10, 253–264. http://dx.doi.org/10.1046/j.1365-2869.2001.00263.x.
Trinder, J., Waloszek, J., Woods, M., Jordan, A., 2012. Sleep and cardiovascular reg-
ulation. Pﬂügers Arch. - Eur. J. Physiol. 463, 161–168. http://dx.doi.org/10.1007/
s00424-011-1041-3.
Weber, E.J.M., Molenaar, C.M., van der Molen, M.W., 1992. A nonstationarity test for the
spectral analysis of physiological time series with an application to respiratory sinus
arrythmia. Psychophysiol 29, 55–65.
Whitehurst, L.N., Cellini, N., McDevitt, E.A., Duggan, K.A., Mednick, S.C., 2016.
Autonomic activity during sleep predicts memory consolidation in humans. PNAS
113, 7272–7277.
L.N. Whitehurst et al. Neurobiology of Sleep and Circadian Rhythms 5 (2018) 52–57
57
